Trump Administration to Pull COVID-19 Vaccines from Market Within Months

The Trump administration plans to remove COVID-19 vaccines from the US market within months, according to a close associate of Health and Human Services Secretary Robert F. Kennedy Jr. COVID-19 vaccine stocks, including Pfizer, BioNTech, Moderna, and Novavax, began trading lower following the update. The decision is based on a 2022 peer-reviewed paper that claimed mRNA vaccines were associated with a higher rate of serious adverse events than placebos in clinical trials. Public health experts have dismissed the study for methodological flaws and downplaying the vaccines' benefits.

The Trump administration is considering withdrawing COVID-19 vaccines from the US market within months, according to a close associate of Health and Human Services Secretary Robert F. Kennedy Jr. This decision is based on a 2022 peer-reviewed paper that claimed mRNA vaccines were associated with a higher rate of serious adverse events than placebos in clinical trials. The announcement has led to a decline in the stock prices of vaccine manufacturers, including Pfizer, BioNTech, Moderna, and Novavax.

Dr. Aseem Malhotra, a British cardiologist and outspoken vaccine critic, has been advising Kennedy and is expected to meet with former President Donald Trump in September to further press his case against the vaccines. Malhotra, who serves as an advisor to the Make America Healthy Again (MAHA) Action group, has cited a study published in the Vaccine journal that suggests a higher risk of adverse events among recipients of mRNA vaccines. However, public health experts have dismissed the study for methodological flaws and downplaying the vaccines' benefits [1].

The decision comes after Kennedy canceled $500 million in funding for mRNA vaccine development and has described the COVID-19 shot as "the deadliest vaccine ever made." This stance has been criticized by more than 750 current and former staff members of the CDC, HHS, and NIH, who signed a letter accusing Kennedy of spreading misinformation and endangering public health [1].

The White House has dismissed the claims as speculation, stating that the administration is relying on "Gold Standard Science" and is committed to radical transparency. However, the potential withdrawal of COVID-19 vaccines could have significant implications for public health and the economy. The decision could also impact the global market for vaccines and affect the stock prices of vaccine manufacturers.

References:
[1] https://indianexpress.com/article/world/trump-rfk-jr-allies-covid-vaccine-ban-within-months-10211686/
[2] https://eurjmedres.biomedcentral.com/articles/10.1186/s40001-025-03060-x